Press Releases

10.03.2022 | The SyncroPatch 384 is installed at the FDA for cardiac safety pharmacology studies

Munich, Germany, March 8th 2022: Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (FDA) at their Silver Spring site in Maryland. The SyncroPatch 384 will be used for high throughput automated patch clamp experiments for cardiac safety experiments.

Read the full press release here.



We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.